Products for Research Use Only
RegisterLogin

CZL-S092

CAT: 0931-T210672-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T210672-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
PLK
Related Pathways
Cell Cycle/Checkpoint
Bioactivity
CZL-S092 is a PLK4 inhibitor with exceptional selectivity for other PLK4 family members (PLK1, PLK2, and PLK3), exhibiting an IC50 of 0.9 nM. It demonstrates antineuroblastoma activity in vitro (IMR-32, IC50 = 1.143 μM) and shows good oral bioavailability in vivo (SD rats, F = 22.1%) . CZL-S092 is applicable in research on various cancers, including neuroblastoma.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-176734CZL-S092
GTR19274614-01CZL-077
HY-168148SCZL-046
PTX26167Anti-Human PCSK9 (S092)
PSM0313Caralolol (CZL) -BSA conjugated antigen
HV275176-01Research Grade Anti-Human PCSK9 (S092)
WM2449-01U-Blot® Cararolol (CZL) Mouse mAb
A136577Anti-PCSK9 (S092) Biosimilar (Monoclonal, IgG)

Popular Products